Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia ; volume:16 ; number:1 ; day:8 ; month:7 ; year:2023 ; pages:1-22 ; date:12.2023
Journal of hematology & oncology ; 16, Heft 1 (8.7.2023), 1-22, 12.2023
- Creator
-
Bennett, Rory
Anderson, Mary Ann
Seymour, John F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-023-01469-7
- URN
-
urn:nbn:de:101:1-2023101208532124691747
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bennett, Rory
- Anderson, Mary Ann
- Seymour, John F.
- SpringerLink (Online service)
Other Objects (12)
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
Response of treatment-naive brain metastases to stereotactic radiosurgery
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
Cognitive Impairment In Treatment-Naïve Bipolar II and Unipolar Depression
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
Treatment-naïve idiopathic inflammatory myopathy: disease evaluation by fluorodeoxyglucose versus pyrophosphate
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
Response of treatment-naive brain metastases to stereotactic radiosurgery
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
Cognitive Impairment In Treatment-Naïve Bipolar II and Unipolar Depression
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
Treatment-naïve idiopathic inflammatory myopathy: disease evaluation by fluorodeoxyglucose versus pyrophosphate
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
Response of treatment-naive brain metastases to stereotactic radiosurgery
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
Cognitive Impairment In Treatment-Naïve Bipolar II and Unipolar Depression
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
Treatment-naïve idiopathic inflammatory myopathy: disease evaluation by fluorodeoxyglucose versus pyrophosphate
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD